Raloxifene protects endothelial cell function against oxidative stress

BACKGROUND AND PURPOSE

Maintaining a delicate balance between the generation of nitric oxide (NO) and removal of reactive oxygen species (ROS) within the vascular wall is crucial to the physiological regulation of vascular tone. Increased production of ROS reduces the effect and/or bioavailability of NO, leading to an impaired endothelial function. This study tested the hypothesis that raloxifene, a selective oestrogen receptor modulator, can prevent endothelial dysfunction under oxidative stress.

EXPERIMENTAL APPROACH

Changes in isometric tension were measured in rat aortic rings. The content of cyclic GMP in aortic tissue was determined by radioimmunoassay. Phosphorylation of endothelial NOS (eNOS) and Akt was assayed by Western blot analysis.

KEY RESULTS

In rings with endothelium, ACh-induced relaxations were attenuated by a ROS-generating reaction (hypoxanthine plus xanthine oxidase, HXXO). The impaired relaxations were ameliorated by acute treatment with raloxifene. HXXO suppressed the ACh-stimulated increase in cyclic GMP levels; this effect was antagonized by raloxifene. The improved endothelial function by raloxifene was abolished by ICI 182,780, and by wortmannin or LY294002. Raloxifene also protected endothelial cell function against H2O2. Raloxifene increased the phosphorylation of eNOS at Ser-1177 and Akt at Ser-473; this effect was blocked by ICI 182,780. Finally, raloxifene was not directly involved in scavenging ROS, and neither inhibited the activity of xanthine oxidase nor stimulated that of superoxide dismutase.

CONCLUSION AND IMPLICATIONS

Raloxifene is effective against oxidative stress-induced endothelial dysfunction in vitro through an ICI 182,780-sensitive mechanism that involves the increased phosphorylation and activity of Akt and eNOS in rat aortae.

Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro

BACKGROUND AND PURPOSE

Raloxifene improves cardiovascular function. This study examines the hypothesis that therapeutic concentrations of raloxifene augment endothelium-dependent relaxation via up-regulation of eNOS expression and activity in porcine coronary arteries.

EXPERIMENTAL APPROACH

Isometric tension was measured in rings from isolated arteries. Intracellular Ca(2+) concentrations ([Ca(2+)](i)) in arterial endothelial cells were detected by Ca(2+) fluorescence imaging. Phosphorylation of eNOS at Ser-1177 was assayed by Western blot analysis.

KEY RESULTS

In arterial rings pre-contracted with 9,11-dideoxy-11alpha,9alpha-epoxy-methano-prostaglandin F(2alpha) (U46619), treatment with raloxifene (1-3 nM) augmented bradykinin- or substance P-induced relaxation and this effect was antagonized by ICI 182,780, an estrogen receptor antagonist. The enhanced relaxation was abolished in rings treated with inhibitors of nitric oxide/cyclic GMP-dependent dilation, N(G)-nitro-L-arginine methyl ester (L-NAME) plus 1H-[1,2,4]oxadizolo[4,3-a]quinoxalin-1-one (ODQ). In contrast, effects of raloxifene were unaffected after inhibition of endothelium-derived hyperpolarizing factors by charybdotoxin plus apamin. Raloxifene (3 nM) did not influence endothelium-independent relaxation to sodium nitroprusside. 17beta-Estradiol (3-10 nM) also enhanced bradykinin-induced relaxation, which was inhibited by ICI 182,780. Treatment with raloxifene (3 nM) did not affect bradykinin-stimulated rise in endothelial cell [Ca(2+)](i). Raloxifene, 17beta-estradiol, and bradykinin increased eNOS phosphorylation at Ser-1177 and ICI 182,780 prevented effects of raloxifene or 17beta-estradiol but not that of bradykinin. Raloxifene had neither additive nor antagonistic effects on 17beta-estradiol-induced eNOS phosphorylation.

CONCLUSIONS AND IMPLICATIONS

Raloxifene in therapeutically relevant concentrations augmented endothelial function in porcine coronary arteries in vitro through ICI 182,780-sensitive mechanisms that were associated with increased phosphorylation of eNOS but independent of changes in endothelial cell [Ca(2+)](i).

Transgenic mice over-expressing endothelin-1 in testis transactivated by a Cre/loxP system showed decreased testicular capillary blood flow

It is generally believed that too high or low levels of endothelin-1 (ET-1), a strong vasoconstrictor, may be detrimental to animals. Therefore, in order to understand the in vivo function of ET-1, we used a conditional transgenic approach, Cre/loxP recombination system, to generate transgenic mice that over-express ET-1 in a tissue-specific manner. In such a strategy a single transgenic mouse line, ELSE, was initially generated where a general promoter, human elongation factor 1alpha (hEF1alpha) promoter, was used to drive the expression of a loxP-flanked sequence containing the lacZ reporter gene and a STOP cassette before the ET-1 cDNA, the recombinational competency of which was confirmed in an Escherichia coli test system. In ELSE mice, expression of the reporter lacZ was limited to spermatozoa and spermatogonia as well as Sertoli, Leydig and endothelial cells in the testis, thus confirming the suitability of these mice for the generation of testes-limited ET-1 expression. To generate transgenic progeny with ET-1 over-expression in the testis (successful recombination, ELSE/ELT), ELSE mice were mated with EIIa-cre mice expressing Cre recombinase in pre-implantation mouse embryos. These ELSE/ELT mice exhibiting testis-specific ET-1 over-expression had normal reproductive function and showed no obvious alterations in gross testicular morphology. Although over-expression of ET-1 leads to reduction of testicular blood flow, young adult ELSE/ELT mice showed no obvious signs of inflammation, fibrosis or abnormal proliferation of cells in the testes of young ELSE/ELT mice by histochemical analyses.

Multiple purinergic receptors lead to intracellular calcium increases in cultured rat Sertoli cells

Our previous study has demonstrated the activation of calcium-dependent Cl(-) secretion through P2Y(2) receptors by extracellular nucleotides. To evaluate the contribution and involvement of other receptor subtypes to this physiological response, the purpose of this study was to investigate the regulation of intracellular calcium concentration ([Ca(2+)](i)) by different purinergic agonists in cultured rat Sertoli cells. Cultured epithelia of Sertoli cells from immature rats were grown on glass coverslips and the purity was confirmed by immunohistochemistry. Intracellular calcium concentration was monitored by microspectrofluorimetric technique using calcium sensitive fluorescent dye Fura-2. Results showed that UTP and ATP consistently increased [Ca(2+)](i). Adenosine, AMP and 2-methylthio-ADP (2-MeSADP) failed to elicit a discernible response. Cross desensitization experiments suggested that the responses to UTP and ATP were mediated by a common receptor population. This is consistent with the presence of receptors belonging to the P2Y(2) subclass. Sertoli cells also responded to 2-methylthio-ATP (2-MeSATP) and ADP but not 2-methylthio-ADP (2-MeSADP) in a concentration-dependent manner. Moreover, the ATP-or UTP-pretreated epithelia continued to respond to ADP, indicating that these cells express at least one additional receptor population that allowed nucleotides to increase [Ca(2+)](i). Apart from the P2Y receptor agonists, the P2X(4) and P2X(7) agonist, 2' and 3'-O-(4-benzoylbenzoyl)-ATP (Bz-ATP), also evoked [Ca(2+)](i) increases in rat Sertoli cells. Messenger RNA transcript corresponding to P2Y(1), P2Y(2), P2X(4) and P2X(7) receptors genes were detected using RT-PCR. Taken together, these data indicate that both metabotropic receptors and ionotropic receptors are present in rat Sertoli cells through which extracellular nucleotides can act.

A novel intubation technique for tracheoesophageal fistula in adults

PURPOSE

To describe a novel technique of tracheal intubation and ventilation in an adult patient with a large tracheoesophageal fistula at the level of the carina.

CLINICAL FEATURES

A 59 yr old woman with squamous cell carcinoma of the esophagus developed a large (2 cm diameter) tracheoesophageal fistula after radiotherapy. The level of her fistula precluded traditional use of a double-lumen endobronchial tube. Intubation and ventilation were managed with two endobronchial tubes. The ability to ventilate or collapse each lung individually was preserved and anesthesia and surgery proceeded uneventfully.

CONCLUSION

Double endobronchial intubation is described to manage anesthesia in an adult patient with a tracheoesophageal fistula at the level of the carina.

Bombesin regulation of adrenocorticotropin release from ovine anterior pituitary cells

Mammalian members of the bombesin-like peptide family (gastrin releasing peptides; GRP) have been localized in the ovine median eminence and in hypophysial-portal blood, suggesting a role in the regulation of anterior pituitary function. In this study we have shown that although bombesin cannot stimulate ACTH secretion alone, it potentiates release by ovine CRF, an effect blocked by the GRP receptor antagonist D-Tyr6bombesin (6-13) propylamide. Bombesin did not potentiate AVP-stimulated ACTH release; instead release was attenuated when bombesin was given at a 10-fold or greater molar excess over AVP, with no interaction seen at lower concentrations. We conclude that ovine corticotrophs express bombesin receptors, and that GRP may act in concert with other hypothalamic releasing factors to regulate ACTH secretion.

Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use

The mechanisms responsible for Norplant implants-induced menstrual irregularities remain poorly understood. It is unclear whether local changes in endometrial haemostasis are involved. The aim of the present study was to examine the immunohistochemical staining for von Willebrand factor (vWF) in endometrial biopsies taken from 37 women exposed to Norplant implants for 3-12 months and to compare it with 73 controls at various phases of the normal menstrual cycle. The vWF staining intensity was quantified by subjective scoring and by objective computerised colour image analysis. Results from the Norplant implants group were additionally correlated with their bleeding patterns, endometrial histology, and plasma oestradiol (E2) and progesterone (P4) levels. No differences were found between control and Norplant implants subjects in the localization of vWF staining, which was specifically confined to the endothelium of endometrial blood vessels. vWF staining intensity in Norplant implants endometrium was significantly lower than in controls during mid cycle, and reached a mean (+/- SE) level (subjective staining score 2.05 +/- 0.13, n = 37) in the range of the early proliferative and mid secretory phase normal endometrium; nevertheless, it remained significantly higher than that of menstrual and late secretory phase normal endometrium. No significant variations in vWF staining could be related to either the histology of the endometrium or the bleeding pattern of the users. Correlation of vWF staining with either serum E2 or serum P4 prior to biopsy, or to the number of days of Norplant implants exposure revealed no significant relationships. However, vWF staining was positively correlated (r = 0.419, P < 0.01) to the number of bleeding/spotting days within a 90-day reference period prior to biopsies being taken. These results demonstrate that there are major differences in the mechanism responsible for normal menstruation and Norplant implants-induced intermenstrual bleeding and spotting, and show that menstrual disturbances associated with the use of Norplant implants are unlikely to be due to changes in vWF levels in endometrial endothelial cells.

Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant

Cytokeratins 8, 18 and 19 are members of the cytoskeletal intermediate filament protein family. They are expressed in all simple epithelial tissues, including endometrium, and are recognised as dynamic structures that can be affected by numerous external factors. The Norplant system is a subdermal slow release levonorgestrel implant commonly used as a long-acting progestogen contraceptive. Norplant implants have been shown to have atrophic effects on endometrial epithelial and stromal cells, and cause a range of endometrial bleeding problems among users. The aim of this study is to describe changes in the immunohistochemical expression and distribution of cytokeratins 8, 18 and 19 in endometrial epithelial cells of Norplant implants users and normal menstrual cycle controls. Endometrial biopsies were collected from 65 control normal cycle women and 37 Norplant implants acceptors. The normal menstrual cycle was classified histologically into 9 stages; one menstrual, five proliferative and three secretory. Norplant implants bleeding patterns were categorised into 6 groups according to current World Health Organisation (WHO) definitions; amenorrhoea, frequent bleeding, infrequent bleeding, irregular bleeding, "normal" bleeding, and prolonged bleeding. The tissues were fixed in formalin, embedded in paraffin, and stained immunohistochemically. Semi-quantitative scoring of the staining intensity was performed. Apical versus basal intracellular cytokeratin distribution was also evaluated. The staining intensity was significantly stronger in control endometrial tissue compared to Norplant implants tissue. In control tissues, cytokeratins were predominantly located in the apical region of epithelial cells (52% of biopsies) and in Norplant implants tissues they were predominantly distributed equally between the apical and basal portions of epithelial cells (43% of biopsies). There was no particular cytokeratin distribution pattern associated with the different stages of normal cycle or the different Norplant implants bleeding patterns. It was concluded that long-term exposure to levonorgestrel significantly reduced the cytokeratin expression in endometrial epithelial cells (P < 0.001).

Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle

The bleeding problems experienced by users of subdermal levonorgestrel implants (Norplant) remain unexplained. The aim of the present study was to investigate the oestrogen (ER) and progesterone receptor (PR) distribution in levonorgestrel-treated endometrial biopsies from 31 subjects recruited in Jakarta, Indonesia, and to compare the sex steroid receptor immunostaining with that of endometrium from 58 normally cycling women from Melbourne, Australia. Sex steroid receptor immunoreactivity was additionally compared with days of exposure to subdermal levonorgestrel, serum oestradiol and progesterone levels and days of bleeding during a 90-day reference period. An immunohistochemical technique with an alkaline phosphatase anti-alkaline phosphatase (APAAP) detection system for use in formalin-fixed paraffin wax embedded endometrial tissue was employed. Significantly greater mean immunostaining scores of stromal PR were observed in Norplant compared with control endometrium at all stages across the cycle. No significant correlations were demonstrated between sex steroid receptor immunostaining and days of exposure to subdermal levonorgestrel, serum oestradiol or progesterone concentrations or days of bleeding during a 90-day reference period. Whether the elevated stromal PR immunostaining in Norplant-treated endometrium is a consequence of increased synthesis or reduced turnover of receptor remains unclear. As yet it is undetermined whether increased PR immunoreactivity corresponds to an increase in number of functional PR.

Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel

The mechanisms that underlie progestogen-induced endometrial breakthrough bleeding are poorly understood. The aim of the present study was to quantify endometrial microvascular density in 54 controls and 42 women with 3-12 months' exposure to Norplant (levonorgestrel subdermal contraceptive implant) and to correlate it with bleeding pattern, endometrial histology, and peripheral plasma oestradiol and progesterone concentrations. Endometrial biopsies were processed routinely and sections immunostained using anti-CD34 antibody to identify vascular endothelial cells. Menstrual record card data were analysed using World Health Organization definitions. The mean microvascular density (+/- SEM) for control samples was 186 +/- 8 vessels/mm2, and there were no significant differences across the cycle. Norplant user's endometrial microvascular density was significantly elevated above controls (294 +/- 18 vessels/mm2, P = 3.36 x 10(-8)). Endometrial microvascular density in Norplant users did not correlate with oestrogen concentrations prior to biopsy, bleeding patterns or endometrial histology. The results from this study show that women receiving Norplant have significantly increased endometrial microvascular density compared to controls. Another finding from this study was that bleeding in Norplant users often occurred from thin atrophic endometrium. These results provide new insights into the physiological mechanisms that may be involved in progestogen-induced endometrial bleeding.

Immunohistochemical staining of von Willebrand factor in human endometrium during normal menstrual cycle

Endometrial biopsies were obtained from 73 normal women throughout the menstrual cycle. Using a polyclonal antibody and a streptavidin-biotin-peroxidase method, formalin-fixed paraffin sections of the tissue were stained for von Willebrand factor (vWF). Both subjective scoring and objective quantitative colour image analysis were used to assess the staining intensity, and the results obtained by the two methods were in concordance with each other. Positive staining was observed at all stages of the menstrual cycle. Specific staining was confined to the vascular endothelium and showed cyclical changes. The staining intensity was the weakest during the menstrual phase and was significantly (P < 0.02) reduced from all other stages of the cycle, except late secretory phase. This was followed by a rapid increase in the early proliferative phase to reach a peak in the mid cycle before gradually falling off towards the end of the cycle. The staining intensity in the late secretory phase was significantly reduced (P < 0.05) from other stages except menstrual, early proliferative and mid secretory phase. Vascular staining for vWF was heterogeneous with some vessels devoid of any positive staining.

Changes in testicular inhibin after a single episode of heating of rat testes

Brief heating (43 C for 15 min) of the scrota of adult rats was used to induce reversible spermatogenic damage to the testes. In these animals the changes in testicular inhibin content and an index of inhibin production rate, measured after efferent duct ligation, were examined and correlated with serum gonadotropin levels. The effect of heating was not evident until after 1 week when testis weight, inhibin content, and inhibin production rate were significantly reduced and both serum FSH and LH were elevated. By 2 weeks, the maximal effects were observed, and, thereafter, all parameters gradually returned to control values (FSH: by 6 weeks; testis and epididymal weight, inhibin content, inhibin production rate, and seminiferous tubule fluid production: by 17 weeks). Throughout the study, serum testosterone levels showed no significant changes. Significant inverse correlations were found between serum FSH levels and inhibin content (r = -0.502, P less than 0.001) or inhibin production rate (r = -0.533, P less than 0.001), and these were taken as supportive evidence for the hypothesis that inhibin is involved in the feedback control of pituitary FSH secretion. Although serum LH levels were also negatively correlated to the corresponding inhibin content (r = -0.669, P less than 0.001) or inhibin production rate (r = -0.420, P less than 0.001), recent findings of Leydig cell dysfunction in these animals led us to relate the transient rise in LH to the altered state of Leydig cell function.

Measurement of inhibin and an index of inhibin production by rat testes during postnatal development

Our previous studies have shown that inhibin activity in rat testes can be measured using an in vitro inhibin bioassay. In animals that have undergone unilateral efferent duct ligation (EDL), the difference in inhibin content between the ligated and nonligated testis can be used as an index of the rate of inhibin production in vivo. In the present study we examined postnatal changes in inhibin content in the testes, and the production rates of inhibin and seminiferous tubule fluid in groups of neonatal, immature, and adult rats from 1 to 80 days old. We detected inhibin activity in testes of 1-day-old rats; the activity level rose linearly to Day 8, subsequently increasing markedly from Day 30 until it reached a plateau at Day 45. Increments in the content of inhibin and weight of the testis after unilateral EDL, interpreted to represent production of inhibin and seminiferous tubule fluid, commenced at Day 20 and increased rapidly between Days 30 and 50, decreasing thereafter to Day 80. The increase in content and production of inhibin was directly correlated to the rise in serum follicle-stimulating hormone (FSH) and testosterone, suggesting that these two hormones are important in controlling inhibin secretion. In addition, the changes in serum FSH from the high, postnatal levels to those typical of adults were inversely correlated to the content and production rate inhibin in the testes and concentrations of testosterone in the serum. These data support the hypothesis that inhibin is specifically involved in the feedback control of pituitary FSH secretion during postnatal development, although a role for testosterone or a synergistic interaction between the two hormones cannot be excluded.

Effects of testosterone on testicular inhibin and fluid production in intact and hypophysectomized adult rats

Rats were given s.c. implants of high (HT) or low (LT) doses of testosterone and 10 days later hypophysectomy or sham-operation was performed. The rats were killed after 50 days. Unilateral efferent duct ligation was performed 16 h before death to measure seminiferous tubule fluid production and the increment in testicular inhibin values (inhibin production). Inhibin levels in testis cytosols were measured by a pituitary cell culture bioassay. The LT implants maintained serum testosterone at control values and decreased testicular weight whereas HT implants raised serum testosterone 3-fold and maintained testicular weight at 75-85% of pretreatment levels. In intact rats, LT implants caused no change in testicular inhibin content but decreased inhibin production; no significant changes occurred with HT implants. After hypophysectomy both values were significantly suppressed and could not be maintained by HT or LT implants. However, the HT implants partly restored inhibin production despite their inability to influence testicular inhibin content. In contrast, tubule fluid production depended mainly on intratesticular testosterone levels and occurred normally in intact or hypophysectomized rats with HT but not LT implants. These results indicate that inhibin and seminiferous tubule fluid production, both functions of the Sertoli cell, are under different hormonal control. The maintenance of inhibin production by the testis requires the support of pituitary hormones, presumably FSH, while seminiferous tubule fluid production requires testosterone, presumably through LH stimulation of Leydig cells. These findings are consistent with the hypothesis that inhibin is produced in response to trophic stimulation by FSH.

Effects of hypophysectomy and subsequent FSH and testosterone treatment on inhibin production by adult rat testes

The hormonal control of inhibin production by adult rat testes was investigated using an in-vitro inhibin bioassay validated for the measurement of inhibin activity in charcoal-treated rat testicular extracts. The effect of hypophysectomy examined at 16 h, 3, 7 and 42 days after surgery showed a decrease in testicular inhibin content and seminiferous tubule fluid production by 7 days and a decrease in inhibin production by 42 days. Serum FSH and LH were suppressed 3 days after surgery. In 30-day chronically hypophysectomized adult rats treated for 3 days with twice daily s.c. injections of (a) human FSH (hFSH, 22 i.u./rat per day), (b) testosterone (5 mg/rat per day), (c) hFSH + testosterone (same doses as a and b), or (d) human chorionic gonadotrophin (hCG, 12 i.u./rat per day), hFSH or hFSH and testosterone stimulated an increase in testicular inhibin content but not in inhibin production or tubule fluid production. Testosterone and hCG had no effect on these parameters. It is concluded that in vivo, FSH alone stimulates an increase in testicular inhibin content. The failure to observe an increase in inhibin production in vivo is attributed to the suppression of seminiferous tubule fluid production under the same experimental conditions.

Relationship between testicular inhibin content and serum FSH concentrations in rats after bilateral efferent duct ligation

The testicular inhibin content showed an initial increase in the first 2-3 days after bilateral ligation of the efferent ducts of rats, followed by a subsequent decline to levels significantly below normal by 14 days, and reached 25% of control values at 42 days. Serum concentrations of FSH and LH were significantly increased at Day 6-7 after treatment and were still elevated after 42 days. The decline in testicular inhibin content at times associated with elevated FSH concentrations is consistent with the hypothesis of inhibin being involved in the feedback control of FSH secretion.

An in-vivo method for estimating inhibin production by adult rat testes

The concentrations of inhibin in samples of rat testicular venous and arterial blood and interstitial fluid were measured by an in-vitro bioassay using pituitary cells in culture in which the standard was an ovine testicular lymph preparation (assigned potency 1 unit/mg). Inhibin levels were undetectable (less than 2 U/ml) in both blood samples but reached a mean concentration of 120 +/- 7 U/ml in testicular interstitial fluid. After unilateral efferent duct ligation the rate of inhibin accumulation in seminiferous tubules was determined by the difference in the inhibin content of the ligated and unligated testes. Additionally, the rate of seminiferous tubule fluid production was obtained from the difference in weight between the ligated and non-ligated testes. In the 24 h after efferent duct ligation there were linear increases in inhibin (18.5 +/- 1.0 U/h) and in seminiferous tubule fluid production (26 +/- 1 microliter/h), but there were no changes in serum FSH and LH levels. Experimental induction of bilateral cryptorchidism led to a decrease in the inhibin content of the testis after 10 days. The rate of inhibin accumulation after efferent duct ligation declined more rapidly than the inhibin content, being significantly depressed in cryptorchid testes after 3 days, suggesting that this measurement is a more sensitive index of inhibin production than the determination of testicular inhibin content.

Biology of the scrotum. II. Suppression by abdominal temperature of transepithelial ion and water transport in the cauda epididymidis

Spermatozoa of scrotal mammals will mature in, but cannot be stored at abdominal temperatures in the epididymis reflected to the abdomen. Whether the failure of sperm storage at abdominal temperatures reflects a temperature sensitivity of the caudal epithelium, or of the spermatozoa, is unknown. Microperfusion of the lumen of the cauda epididymis revealed that abdominal temperature soon brings a significant change in the transepithelial transport of water, Na+, K+ and Cl-, and in the Na+ and K+ levels in the luminal fluids in the cauda. Thus, the cauda epididymis, as well as the testis, behaves as a temperature-dependent organ.

The use of 51Cr for assessing cytotoxicity in an in vitro bioassay for inhibin

A cytotoxicity test based on 51Cr release was investigated to assess the specificity of an in vitro bioassay for inhibin utilizing rat anterior pituitary cells in culture. The bioassay is based on a specific suppression of the pituitary cell content of FSH. A variety of substances both of known and unknown toxicity, were bioassayed for inhibin at serial dilutions and the 51Cr release, and FSH and LH cell content levels determined and morphological appearance of the cells evaluated. Results indicated that the 51Cr release procedure was more sensitive and specific in assessing cytotoxicity than either morphological evaluation or LH cell content procedures. In addition, since the 51Cr release was largely independent of the 51Cr concentration, the cell concentration and the age of the culture (2-6 days), this method could be used to assess the quality of, or differences between individual cultures. In conclusion, the 51Cr release procedure provides an additional index for assessing the specificity of the inhibin bioassay as well as an index of the quality of individual cultures. The simplicity and high precision of this cytotoxicity test make it an attractive adjunct to other in vitro bioassay methods.

Luminal acidification by the perfused rat cauda epididymidis

1. Acid secretion by the rat cauda epididymidis was studied by microperfusion of the epididymal duct and by measuring the pH of the perfusate at a constant pCO(2) using a micro pH sensitive electrode. The rate of acidification was expressed as the rate of fall of intraluminal bicarbonate per cm duct per min.2. When the cauda epididymal duct was perfused with normal bicarbonate solution, the luminal bicarbonate concentration fell at a rate of 0.59 +/- 0.39 n-equiv cm(-1) min(-1) (mean +/- s.e.,n = 22).3. The rate of luminal acidification was independent of the perfusion rate but was dependent on the concentration of bicarbonate in the perfusion fluid. The rate of fall of luminal bicarbonate increased with increasing bicarbonate concentration and showed saturation at an intraluminal bicarbonate concentration of 25 m-mole/l.4. Acidification was abolished in the absence of intraluminal sodium ions. This may suggest a linked sodium reabsorption and hydrogen ion secretion.5. Acidification of the luminal fluid was studied under different acid-base conditions. In animals undergoing metabolic acidosis, the rate of acidification was enhanced, and conversely in animals undergoing metabolic alkalosis, the rate was depressed.6. Intravenous infusion of acetazolamide into rats at a dose rate of 20 mg/kg.hr markedly inhibited the acidification process. This effect was still observed in animals undergoing metabolic acidosis. Acetazolamide (10(-5)m) applied luminally was found to have no effect but higher concentration (10(-4)m) was found to inhibit acidification by 50%.7. The role of acidification of the epididymal fluid in sperm maturation was discussed.

Effects of 6-chloro-6-deoxyglucose on electrolyte and water transport in the epididymis and fertility of male rats

The effects of 6-chloro-6-deoxyglucose (6 CDG) on the transport of electrolytes and water in the cauda epididymidis and fertility of male rats were studied. Injection of 6 CDG into male rats at a dose rate of 120 muM/kg/day for 7-14 days induced sterility and inhibited sodium and water reabsorption in the perfused cauda epididymidis by about 60%. The rates of potassium and protein secretion were unaffected. When these rats were allowed to recover for 10 weeks, both fertility and the Na and water reabsorption of the cauda were restored. It is proposed that the chlorinated sugar may affect epididymal sperm metabolism through an effect on the transport function of the epididymis.

The isolated duct of the rat cauda epididymidis as a model for isosmotic transport studies

Electrolytes and water transport have been studied in the perfused isolated duct of the rat cauda epididymis in vitro. The rates of reabsorption of sodium, chloride and water and of secretion of potassium were found to be comparable to those in the perfused rat cauda epididymidis in vivo. Sodium reabsorption was isotonic and inhibited by the metabolic uncoupler 2,4-dinitrophenol and cooling. Removal of sodium ions from the intraluminal fluid abolished water reabsorption in the isolated duct. When potassium ions were removed from the peritubular medium the secretion of potassium was abolished, but the reabsorption of sodium and water was unaffected. Under this condition, the reabsorption of chloride was enhanced. Removal of calcium ions from the lumen increased the rates of sodium and water reabsorption and potassium secretion by twofold. Amiloride (10(-4) M) added to the intraluminal fluid had no effect on the electrolyte and water transport in the isolated duct, whereas triaminopyrimidine produced a dose-dependent inhibition of sodium and water reabsorption when added to both sides. Sodium and water reabsorption were found to be inhibited by the application of ouabain (10(-3) M) to the peritubular side and of ethacrynic acid (10(-4) to 10(-5) M) to the luminal peritubular side and of ethacrynic acid (10(-4) to 10(-5) M) to the luminal side. These results are discussed in the light of the recent concepts of isosmotic transepithelial transport.